Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin

Sanofi lost an appeals court ruling on its patent-infringement claims against Roche Holding AG’s Genentech and Biogen Idec Inc. for the cancer drugs Rituxan and Avastin.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.